| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 18,693 | 12,475 | | Cost of Revenue |
-
|
-
| | | Gross Profit | 18,693 | 12,475 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 6,980 | 2,707 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 11,713 | 9,768 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,961) | (714) | | Earnings Before Interest And Taxes | 8,530 | 5,791 | | Interest Expense |
-
| 3,246 | | Income Before Tax | 8,530 | 2,545 | | Income Tax Expense | (3,182) | 3,263 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 10,934 | 2,545 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 10,934 | 2,545 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $10,934 | $2,545 |
|
1.48% Nasdaq 
Income Statement
